A patient, newly diagnosed with a peptic ulcer, needs more education when he states:

A. Replacement therapy with pancreatic enzymes: Pancreatic insufficiency results in a lack of digestive enzymes, leading to malabsorption of nutrients. Enzyme replacement therapy is essential to aid in digestion and nutrient absorption.
B. Treatment with stimulant laxatives: Stimulant laxatives are used to treat constipation by increasing bowel motility. They do not address the underlying enzyme deficiency in pancreatic insufficiency and can potentially cause further nutrient loss.
C. Treatment with PPIs to decrease stomach acid: Proton pump inhibitors (PPIs) reduce stomach acid production and are used for conditions like GERD. They do not address the enzyme deficiency caused by pancreatic insufficiency.
D. Decrease food intake: Reducing food intake does not treat pancreatic insufficiency and can lead to malnutrition. The goal is to support normal digestion and nutrient absorption through enzyme replacement.

A. Respiratory rate and pulse: Albuterol is a bronchodilator that works by relaxing the muscles in the airways, improving airflow and reducing wheezing and shortness of breath. After administration, it is important to monitor the respiratory rate to assess the patient’s breathing status and any changes in work of breathing. The pulse should also be monitored because albuterol can cause tachycardia as a side effect. An increase in heart rate is a common reaction to this medication and needs to be assessed to ensure it remains within safe limits.
B. Glucose: Monitoring glucose levels is not typically necessary after administering albuterol unless the patient has diabetes or there is a specific concern for hyperglycemia. Albuterol can cause an increase in blood glucose levels, but this is usually not a primary concern for an acute respiratory distress assessment unless the patient has an underlying condition that warrants it.
C. Pulse oximetry: Pulse oximetry measures the oxygen saturation in the blood, which is crucial for evaluating the effectiveness of albuterol in improving oxygenation. An increase in oxygen saturation levels after administration would indicate improved ventilation and gas exchange. Given that the patient initially has a pulse oximetry reading of 91%, it is important to reassess this to ensure that oxygen levels are improving with treatment.
D. Capillary refill: While capillary refill is an important general assessment for perfusion and circulatory status, it is not specifically required to evaluate the effectiveness of albuterol. It is more relevant in assessing overall circulation rather than the respiratory status directly impacted by albuterol.
E. Lung sounds: Reassessing lung sounds is critical after administering albuterol. The goal is to observe for changes such as reduced wheezing or improved airflow, which would indicate that the bronchodilator is effectively opening the airways. Listening for any changes in breath sounds helps to evaluate the patient’s response to the medication and detect any potential complications like paradoxical bronchospasm.